中国高血压患病率、知晓率、治疗率与控制率2004-18年:六轮全国调查
该研究基于2004-18年六轮中国慢性病与危险因素监测,纳入642 523名18-69岁社区居民。年龄标化高血压患病率从2004年20.8%升至2010年29.6%,后降至2018年24.7%;
要点
- 2018年中国18-69岁成人年龄标化高血压患病率为24.7%。
- 2018年高血压知晓率38.3%、治疗率34.6%、控制率12.0%,均处低位。
核心结论
- 中国高血压患病率自2010年以来略有下降,但治疗率和控制率仍较低。
- 研究提示需通过加强基层医疗(尤其农村地区)提高高血压的检出和治疗。
研究设计与样本
- 研究设计为六轮全国调查(中国慢性病与危险因素监测,2004-18年)。
- 共纳入642 523名18-69岁社区居民,各轮样本量分别为2004年30 501人、2007年47 353人、2010年90 491人、2013年156 836人、2015年162 293人、2018年155 049人。
- 高血压定义为血压≥140/90 mm Hg或正在服用降压药。
主要发现
- 18-69岁成人年龄标化高血压患病率从2004年20.8%(95%CI 19.0%-22.5%)升至2010年29.6%(95%CI 27.8%-31.3%),后降至2018年24.7%(95%CI 23.2%-26.1%)。
- 2010-18年间女性高血压患病率的绝对年下降幅度(-0.83个百分点,95%CI -1.13至-0.52)超过男性的两倍(-0.40个百分点,95%CI -0.73至-0.07)。
- 2018年高血压知晓率为38.3%(95%CI 36.3%-40.4%)、治疗率34.6%(95%CI 32.6%-36.7%)、控制率(血压<140/90 mm Hg)12.0%(95%CI 10.6%-13.4%)。
- 所有调查中,低教育程度女性的高血压患病率高于高教育程度女性,男性中该发现不一致;城乡高血压控制差距持续存在,尽管农村诊断和控制改善幅度大于城市。
关键数值与推荐
- 高血压诊断标准:血压≥140/90 mm Hg或服用降压药。
- 控制标准:血压<140/90 mm Hg。
- 2018年年龄标化高血压患病率为24.7%(95%CI 23.2%-26.1%)。
- 2018年知晓率38.3%、治疗率34.6%、控制率12.0%。
临床怎么用
- 全科医生应加强社区高血压筛查,提高知晓率和治疗率。
- 对已治疗患者应强化血压管理,提高血压控制率。
- 应重点关注农村地区和低教育程度人群的高血压检出与控制。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the recent trends in prevalence and management of hypertension in China, nationally and by population subgroups. DESIGN: Six rounds of a national survey, China. SETTING: China Chronic Disease and Risk Factors Surveillance, 2004-18. PARTICIPANTS: 642 523 community dwelling adults aged 18-69 years (30 501 in 2004, 47 353 in 2007, 90 491 in 2010, 156 836 in 2013, 162 293 in 2015, and 155 049 in 2018). MAIN OUTCOME MEASURES: Hypertension was defined as a blood pressure of ≥140/90 mm Hg or taking antihypertensive drugs. The main outcome measures were hypertension prevalence and proportion of people with hypertension who were aware of their hypertension, who were treated for hypertension, and whose blood pressure was controlled below 140/90 mm Hg. RESULTS: The standardised prevalence of hypertension in adults aged 18-69 years in China increased from 20.8% (95% confidence interval 19.0% to 22.5%) in 2004 to 29.6% (27.8% to 31.3%) in 2010, then decreased to 24.7% (23.2% to 26.1%) in 2018. During 2010-18, the absolute annual decline in prevalence of hypertension among women was more than twice that among men (-0.83 percentage points (95% confidence interval -1.13 to -0.52) v -0.40 percentage points (-0.73 to -0.07)). Despite modest improvements in the awareness, treatment, and control of hypertension since 2004, rates remained low in 2018, at 38.3% (36.3% to 40.4%), 34.6% (32.6% to 36.7%), and 12.0% (10.6% to 13.4%). Of 274 million (95% confidence interval 238 to 311 million) adults aged 18-69 years with hypertension in 2018, control was inadequate in an estimated 240 million (215 to 264 million). Across all surveys, women with low educational attainment had higher prevalence of hypertension than those with higher education, but the finding was mixed for men. The gap in hypertension control between urban and rural areas persisted, despite larger improvements in diagnosis and control in rural than in urban areas. CONCLUSIONS: The prevalence of hypertension in China has slightly declined since 2010, but treatment and control remain low. The findings highlight the need for improving detection and treatment of hypertension through the strengthening of primary care in China, especially in rural areas.
引用
- Zhang M, Shi Y, Zhou B, et al. Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey. BMJ. 2023. PMID: 36631148. doi:10.1136/bmj-2022-071952
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。